109
Views
2
CrossRef citations to date
0
Altmetric
Original Research

The purpose and appropriateness of carbapenem use in a single university hospital, 2009–2013

, , , , , , , , , & show all
Pages 863-865 | Received 16 Dec 2015, Accepted 24 Feb 2016, Published online: 15 Mar 2016

References

  • Van Boeckel TP, Gandra S, Ashok A, et al Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. The Lancet. Infectious Diseases. 2014;14(8):742–750.
  • Yamamoto M, Pop-Vicas AE. Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have? Crit Care. 2014;18(3):229.
  • Ogutlu A, Guclu E, Karabay O, et al. Effects of carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients. Ann Clin Microbiol Antimicrob. 2014;13:7.
  • McLaughlin M, Advincula MR, Malczynski M, et al. Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae. Antimicrob Agents Chemother. 5131-5133;57(10):2013.
  • Cao J, Song W, Gu B, et al. Correlation between carbapenem consumption and antimicrobial resistance rates of Acinetobacter baumannii in a university-affiliated hospital in China. J Clin Pharmacol. 2013;53(1):96–102.
  • Jary F, Kaiser JD, Henon T, et al. Appropriate use of carbapenems in the Besancon university hospital. Med Mal Infect. 2012;42(10):510–516.
  • Apisarnthanarak A, Mundy LM. Inappropriate use of carbapenems in Thailand: a need for better education on de-escalation therapy. Clin Infect Dis. 2008;47(6):858–859.
  • Brink AJ, Feldman C, Grolman DC, et al. Appropriate use of the carbapenems. S Afr Med J. 2004;94(10 Pt 2):857–861.
  • The WHO Collaborating Centre for Drug Statistics Methodology. ATC Index with DDDs [Internet] . 2015 [cited 2015 Dec 17]. Available from: http://www.whocc.no/atc_ddd_publications/atc_ddd_index/
  • Kasper DL. Harrison’s principles of internal medicine, 19th edition. New York (NY): McGraw-Hill Education; 2015.
  • Scholossberg D. Current therapy of infectious disease. Maryland Heights (MO): Mosby; 2001.
  • Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–228.
  • Latin America Working Group on Bacterial R, Guzmán-Blanco M, Labarca JA, Villegas MV, et al. Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America. Braz J Infect Dis. 2014;18(4):421–433.
  • Brolund A, Edquist PJ, Makitalo B, et al Epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in Sweden 2007-2011. Clin Microbiol Infect. 2014;20(6):O344–352.
  • Jeon MH, Kim TH, Kim SR, et al. Korean nosocomial infections surveillance system, intensive care unit module report: summary of data from July 2011 through June 2012. Korean J Nosocomial Infect Control. 2014;19(2):52.
  • The Korea Centers for Disease Control and Prevention. Korean Antimicrobial Resistance Monitoring System [Internet]. 2015. [cited 2015 Aug 21]. Available from: http://www.cdc.go.kr/CDC/contents/CdcKrContentView.jsp?cid=24324&viewType=CDC&menuIds=HOME001-MNU1175-MNU1192-MNU1196
  • Dellit TH, Owens RC, McGowan JE Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–177.
  • Heenen S, Jacobs F, Vincent JL. Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often? Crit Care Med. 2012;40(5):1404–1409.
  • De Waele JJ, Ravyts M, Depuydt P, et al. De-escalation after empirical meropenem treatment in the intensive care unit: fiction or reality? J Crit Care. 2010;25(4):641–646.
  • Thibaut S, Caillon J, Marquet A, et al. Epidemiology of third-generation cephalosporin-resistant community-acquired Enterobacteria isolated from elderly patients. Med Mal Infect. 2014;44(2):57–62.
  • Denis B, Lafaurie M, Donay JL, et al. Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study. Int J Infect Dis. 2015;39:1–6.
  • Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control. 1995;23(2):87–94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.